3.1 Summary of material accounting policies (also refer
note 3.2)
a. Property, plant and equipment
Property, plant and equipment are measured and carried at cost, net of accumulated depreciation and impairment, if any. Costs directly attributable to acquisition/construction are capitalized until the property, plant and equipment are ready for use, as intended by the management.
Depreciation on property, plant and equipment is provided on a straight-line basis so as to expense the cost less residual value over their estimated useful lives as prescribed in Schedule II of the Companies Act, 2013 except in respect of certain assets, where the useful life of the assets has been assessed based on a technical evaluation and management estimate. The management believes that these estimated useful lives are realistic and reflect fair approximation of the period over which the assets are likely to be used. The estimated useful lives and residual values are reviewed at
the end of each reporting period and any change in estimate is accounted for on a prospective basis. The estimated useful lives are as mentioned below:
Assets costing '5,000 or less are depreciated within one year of the date they were first put to use.
Advances paid towards the acquisition of property, plant and equipment outstanding at each reporting date are classified as capital advance and disclosed under other non-current assets.
Cost incurred for property, plant and equipment that are not ready for their intended use as on the reporting date, is classified under capital work- in-progress. The cost of self-constructed assets includes the cost of materials & direct labour, any other costs directly attributable to bringing the assets to the location and condition necessary for it to be capable of operating in the manner intended by management and the borrowing costs attributable to the acquisition or construction of a qualifying asset. Expenses directly attributable to construction of property, plant and equipment incurred till they are ready for their intended use are identified and allocated on a systematic basis to the cost of related assets.
An item of property, plant and equipment and any significant part initially recognised is derecognised upon disposal or when no future economic benefits are expected from its use or disposal. Any gain or loss arising on derecognition of the
asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the Statement of Profit and Loss when the asset is derecognised.
b. Goodwill and Other intangible assets
Goodwill is initially measured at cost, being the excess of the aggregate of the consideration over the net of identifiable assets acquired and liabilities assumed. If the fair value of the net assets acquired is in excess of the aggregate consideration transferred, the Company re¬ assesses whether it has correctly identified all of the assets acquired and all of the liabilities assumed and reviews the procedures used to measure the amounts to be recognised at the acquisition date. If the reassessment still results in an excess of the fair value of net assets acquired over the aggregate consideration transferred, then the gain is recognised in OCI and accumulated in equity as capital reserve. However, if there is no clear evidence of bargain purchase, the entity recognises the gain directly in equity as capital reserve, without routing the same through OCI. After initial recognition, goodwill is measured at cost less any accumulated impairment losses.
Other intangible assets acquired are measured on initial recognition at cost and carried at cost less accumulated amortization and accumulated impairment losses, if any. The intangible assets acquired in a business combination are measured at their fair value on the date of acquisition. Internally generated intangible assets are recognised only to the extent that the related development costs meet the criteria for capitalisation.
Intangible assets with indefinite useful lives i.e. Goodwill and Trademarks are not amortized, but are tested for impairment annually or whenever there is an indication that the recoverable amount of a Cash Generating Unit (“CGU”) is less than its carrying amount either individually or at the cash-generating unit level. The assessment of indefinite life for trademark is reviewed annually to determine whether the indefinite life continues to be supportable. If not, the change in useful life from indefinite to finite is made on a prospective basis.
Intangible assets with finite lives are amortized on a straight line basis over their estimated useful economic lives and assessed for impairment
whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. The amortization period and the amortization method for an intangible asset with a finite useful life is reviewed periodically. Following table summarizes the nature of intangible assets and their estimated useful lives.
Medical service agreements represent the long term arrangement with third party hospitals categorised as Partner Healthcare Facility (“PHF”). Such rights are amortized on straight line basis over the contract period.
Operation and management rights represent the exclusive right to equip, administer, upgrade, manage, operate and supervise the Dr. B.L Kapur Memorial Hospital (a hospital of The Lahore Hospital Society) and Max Super Speciality Hospital Dwarka (a unit of Muthoot Hospital Private Limited) (referred to as deemed separate entities i.e. ‘Silos’). Such rights are amortized on straight line basis over the contract period.
Gains or losses on derecognition of goodwill and other intangible assets are measured as the difference between the net proceeds from disposal, if any, and the carrying amount of such asset and are recognised in the Statement of Profit and Loss when the asset is derecognised.
c. Impairment assessmentGoodwill and other non financial assets
Goodwill is allocated to each of the cash-generating units (“CGU”) (or groups of cash-generating units) that is expected to benefit from the synergies of the combination. A CGU is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or group of assets.
A cash-generating unit to which goodwill and other non financial assets have been allocated is tested for impairment on an annual basis and/ or whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. If the recoverable amount of a CGU is less than its carrying amount, the impairment loss is first allocated to the goodwill of the respective CGU. Excess impairment loss over the goodwill is allocated on all the remaining assets of the respective CGU in the ratio of their respective carrying values. An impairment loss on assets (including goodwill) is recognised in the Statement of Profit and Loss. Such impairment loss is subsequently reversed (except in the case of goodwill) if there is an increase in the recoverable amount of the assets arising from a change in estimates, subject to the carrying amount not exceeding the original carrying amount. Upon disposal of the relevant CGU, the portion of goodwill attributable to that CGU is included in the calculation of gain or loss on disposal.
The recoverable amount of CGUs is determined based on higher of value in use and fair value less cost to sell. Key assumptions in the cash flow projections are based on current economic conditions, estimated long-term growth rates and weighted average cost of capital and estimated operating margins. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of time value of money and the risks specific to the asset for which the estimates are made.
For assets excluding goodwill, the Company reviews the carrying amounts of its property, plant and equipment and intangible assets to assess whether there is any indication that such assets may be impaired. If any such indication exists, the recoverable amount of the asset is reassessed to determine the extent of any impairment loss. Where it is not possible to estimate the recoverable amount of an individual asset, the Company determines the recoverable amount of the CGU to which the asset belongs.
Further, for assets excluding goodwill, an assessment is made at each reporting date to determine whether there is an indication that previously recognised impairment losses no
longer exist or have decreased. If such indication exists, the Company estimates the asset’s or CGU’s recoverable amount. A previously recognised impairment loss is reversed only if there has been a change in the estimates assumptions used to determine the asset’s recoverable amount since the last impairment loss was recognised. The carrying amount of the asset is increased to its revised recoverable amount, provided that this amount does not exceed the carrying amount that would have been determined (net of any accumulated depreciation) had no impairment loss been recognised for the asset in prior years. Such reversal is recognised in the Statement of Profit and Loss unless the asset is carried at a revalued amount, in which case, the reversal is treated as a revaluation increase.
d. Investment property
Property that is held for long-term rental yields or for capital appreciation or for both, is classified as investment property. Investment property is measured initially at cost, including transaction costs. Subsequent to initial recognition, investment property is stated at cost less accumulated depreciation and accumulated impairment loss, if any.
Transfers to, or from, investment properties are made at the carrying amount when there is a change in use.
An item of investment property is derecognised upon disposal or when no future economic benefits are expected to arise from the continued use of asset. Any gain or loss arising on the disposal or retirement of an item of investment property is determined as the difference between the sales proceeds, if any and the carrying amount of the property and is recognised in the Statement of Profit and Loss. Income received from investment property is recognised in the Statement of Profit and Loss on a straight line basis over the term of the lease.
Investment property is depreciated using the straight-line method over their estimated useful life.
e. Financial Instruments Initial recognition
A financial instrument is any contract that gives rise to a financial asset of one entity and a
financial liability or equity instrument of another entity. The Company recognizes financial assets and financial liabilities when it becomes a party to the contractual provisions of the instrument. All financial assets and liabilities are recognized at fair value on initial recognition, except for trade receivables which are initially measured at transaction price. Transaction costs that are directly attributable to the acquisition or issue of financial assets or financial liabilities, which are not at fair value through profit or loss, are added to the fair value on initial recognition.
Subsequent recognition
Financial assets carried at amortized cost
A financial asset is subsequently measured at amortized cost if it is held, within a business model whose objective is to hold the asset in order to collect contractual cash flows and the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest thereon.
Financial assets carried at fair value through other comprehensive income (FVTOCI) (debt instruments)
A financial asset is subsequently measured at fair value through other comprehensive income if it is held within a business model whose objective is achieved by both collecting contractual cash flows and selling such financial asset and the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest thereon.
Financial assets carried at fair value through other comprehensive income (FVTOCI) (equity instruments)
Upon initial recognition, the Company elects to classify irrevocably its equity investments as equity instruments designated at fair value through OCI when they meet the definition of equity under Ind AS 32 ‘Financial Instruments: Presentation’ for the issuer and are not held for trading. The classification is determined on an instrument-by-instrument basis. Equity investments which are held for trading and contingent consideration recognised by an acquirer in a business combination to which Ind AS 103 applies are classified as at FVTPL.
Gains and losses on these financial assets are never recycled to profit or loss. Dividends are recognised as other income in the Statement
of Profit and Loss when the right to receive has been established, except when the Company benefits from such proceeds as a recovery of part of the cost of the financial asset, in which case, such gains are recorded in OCI. Equity instruments designated at fair value through OCI are not subject to impairment assessment. The Company elected to classify irrevocably its non-listed equity investments under this category.
Financial assets at fair value through profit or loss
A financial asset which is not classified in any of the above categories is subsequently fair valued through profit or loss.
(i) Financial assets Trade receivables
Trade receivables from healthcare services are recognised and billed at amounts estimated to be collectable under government reimbursement programs, reimbursement arrangements with third party administrators and insurance, contractual arrangements with corporates including public sector undertakings and individual customers. The billing on government reimbursement programs is at pre-determined net realizable contracted rates per treatment that are established by statute or regulation. Revenues for non-governmental payors with which the Company has contracts are recognised at the prevailing contract rates. The remaining non-governmental payors are billed at the Company’s standard rates for services and a contractual adjustment is recorded to recognize revenues based on historic reimbursement. The contractual adjustment and the allowance for doubtful accounts and the collectability of receivables are reviewed on a regular basis.
Unbilled revenue
Unbilled revenue represents value of services rendered to the customers and for which invoice has not been raised. These are reported under other current financial assets.
I mpairment and derecognition of financial assets
In accordance with Ind AS 109, the Company applies expected credit losses (“ECL”)
model for measurement and recognition of impairment loss on the following financial asset and credit risk exposure.
(a) Financial assets measured at amortized cost;
(b) Financial assets measured at fair value through other comprehensive income (“FVTOCI”);
The Company follows “simplified approach” for recognition of allowance for impairment loss on trade receivables. Accordingly, under the simplified approach, the Company does not track day to day changes in credit risk. Rather, it recognises allowance for impairment loss based on lifetime ECLs at the time of initial revenue recognition. The Company uses a provision matrix to determine allowance for impairment loss allowance on the portfolio of trade receivables. The provision matrix is based on the empirical evidence over the expected life of various categories of trade receivables and these are reviewed and updated based on forward looking estimates at every reporting date.
For recognition of impairment losses on other financial assets and assessment of risk exposure, the Company determines whether there has been a significant increase in the credit risk since initial recognition. If credit risk has not increased significantly since initial recognition, 12-month ECL is used to measure the impairment loss allowance. However, if credit risk has increased significantly since initial recognition, lifetime ECL is used. If, in a subsequent period, credit quality of the financial instrument improves such that there is no longer a significant increase in credit risk since initial recognition, then the Company reverts to measuring the impairment loss allowance based on 12-months ECL.
The Company derecognises a financial asset when the contractual rights to the cash flows from the financial asset expire or it transfers the financial asset and such transfer qualifies for derecognition under Ind AS 109.
(ii) Financial liabilities Trade Payables
These amounts represent liabilities for goods and services availed by the Company prior to
the end of the financial year which are unpaid. Trade and other payables are presented as Current Liabilities if payments are due within 12 months of the end of reporting date.
Borrowings
Interest-bearing borrowings are measured at amortized cost using the Effective Interest Rate (“EIR”) method and included in finance costs. Gain or loss is recognised in Statement of Profit and Loss when the liability is derecognised. Amortised cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the EIR. Impact of liquidity risk has been disclosed in notes.
Derecognition
A financial liability (or a part thereof of a financial liability) is derecognised when the obligation specified in the contract is discharged or cancelled or expires.
. Investment in subsidiaries
The investment in subsidiaries, except for the ones fair valued on business combination is carried at cost, less impairment if any, as per Ind AS 27. The Company, regardless of the nature of its involvement with an entity (the investee), determines whether it is a parent by assessing if it controls the investee. Control on an investee is demonstrated when the Company is exposed, or has rights to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee.
On disposal of investment, the difference between its carrying amount and net disposal proceeds is charged or credited to the Statement of Profit and Loss.
Impairment of investments
The Company reviews its carrying value of investments annually, or more frequently when there is an indication for impairment. If the recoverable amount is less than its carrying amount, the impairment loss is recorded in the Statement of Profit and Loss. When an impairment loss subsequently reverses, the carrying amount of the Investment is increased to the revised estimate of its recoverable amount, so that the increased carrying amount does not exceed the cost of the investment. A reversal of
an impairment loss is recognised in the Statement of Profit or Loss.
g. Business combinationBusiness combination other than under com¬ mon control
In ‘acquisition method of accounting’, the cost of an acquisition is measured at fair value of the assets acquired, equity instruments issued and liabilities incurred or assumed at the date of acquisition, which is the date on which control is transferred to the Company. The cost of acquisition also includes the fair value of any contingent consideration. Acquisition related costs are recognised in profit and loss as incurred.
At the date of acquisition, the identifiable assets acquired and liabilities including contingent liabilities assumed are measured initially at their fair value, except that:
a) deferred tax assets or liabilities and assets or liabilities related to employee benefit arrangements are recognised and measured in accordance with Ind AS 12 and Ind AS 19 respectively;
b) liabilities or equity instruments related to share-based payments arrangement of the acquiree or share-based arrangements of the group entered into to replace share-based payment arrangements of the acquiree are measured in accordance with Ind AS 102 at the acquisition date; and
c) assets (or disposal group) that are classified as held for sale in accordance with Ind AS 105 are measured in accordance with that standard.
Business combination under common control
Business combinations involving entities or businesses in which all the combining entities or businesses are ultimately controlled by the same party or parties both before and after the business combination and where control is not transitory, are accounted for as per the pooling of interest method. The accounting for the business combination is carried out from the beginning of the earliest comparative period presented. The assets and liabilities of the combining entities are recognised at their carrying amounts. The identity of the reserves is preserved and appears in the financial statements of the transferee in the
Where the Company receives advance payments from customers containing the significant financing component, then the transaction price for these contracts is adjusted using the interest rate implicit in the contract (i.e., the interest rate that discounts the cash selling price to the amount paid in advance). This rate is commensurate with the rate that would be reflected in a separate financing transaction between the Company and the customer at contract inception.
(a) Sale of goods
Revenue from sale of pharmacy and pharmaceutical supplies is recognised at a point in time when control of the goods is transferred to the customer, generally on delivery of the pharmacy and pharmaceutical items. The Company collects goods and services tax (“GST”), if applicable, on behalf of the government and, therefore, these are not economic benefits flowing to the Company and thus are excluded from revenue. Revenue towards satisfaction of a performance obligation is measured at the amount of transaction price (net of variable consideration on account of various discounts and schemes offered by the Company as part of the contract) allocated to that performance obligation.
(b) Revenue from healthcare services
Revenue from rendering of healthcare services (including drugs, consumables and implants used in delivery of such services) is recognised over the period of time, based on the performance of related services to the customers as per the terms of contract. Revenue from healthcare patients, third party payors and other customers is recorded at the transaction price which is the amount of consideration that the Company expects to be entitled in exchange for the services rendered, net of disallowances, discounts or rebates.
(c) Other services rendered
Income from other services like food and beverage, sponsorship income, education income, clinical trials and
same form in which they appeared in the financial statements of the transferor. The difference, if any, between the consideration and the amount of share capital of the transferor entity is transferred to capital reserve. The consequential impact of such business combination on the carrying values of deferred tax assets and/or deferred tax liabilities in the hands of combined entity is reassessed and change, if any, is recognised in the Statement of Profit and Loss.
h. RevenueI) Revenue from contracts with customers
The Company earns revenue primarily by providing healthcare services and sale of drugs and medical consumables. The Company also earns revenue through medical services agreements, laboratory services and operation and management contracts. Revenue from contracts with customers is recognised when control of the goods is transferred or services are rendered to the customer at an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services net of returns and allowances, trade discounts and volume rebates. Revenue is usually recognised when it is probable that economic benefits associated with the transaction will flow to the entity, amount of revenue can be measured reliably and entity retains neither ownership nor effective control over the goods sold or services rendered. Contracts with customers could include promises to transfer multiple services to a customer. The Company assesses the services promised in a contract and identifies distinct performance obligations in the contract. Revenue for each distinct performance obligation is measured at an amount that reflects the consideration which the Company expects to receive in exchange for services. Further, revenue recognised is net of applicable discounts, allowances and tax collected from customers. The Company also determines whether the performance obligation is satisfied at a point in time or over a period of time. These judgments and estimates are based on various factors including contractual terms and historical experience.
other ancillary activities is recognised based on the terms of the contract and when it is probable that economic benefits associated with the transaction will flow to the Company and amount of revenue can be measured reliably.
II) Rental income
Rental income arising from operating leases and investment property are accounted as per their respective terms of contract.
III) Incentive Income
Export Promotion Capital Goods (‘EPCG’) scheme allows import of capital goods at zero customs duty subject to an export obligation of upto six times of customs duty saved on capital goods imported under EPCG scheme, to be fulfilled in six years reckoned from authorisation issue date. The Company has been availing the benefit and importing capital goods under the scheme at zero customs duty. The Company has accounted for the benefits received in accordance with Ind AS 20 - Accounting for Government Grants and Disclosure of Government Assistance’. The benefit (savings of customs duty equivalent to non-cenvatable portion) obtained from the Government has been treated as a Government grant, which has been accounted for as Deferred government grant for Export Promotion Capital Good (‘EPCG’) Licence under other non-current liabilities and recognised as a cost of property, plant and equipment. The deferred benefit is credited to Statement of Profit and Loss on a pro-rata basis as and when the export obligation is fulfilled.
IV) Other income(a) Interest income
I nterest income is recognised on a time proportion basis taking into account the amount outstanding and the applicable effective interest rate. Interest income is included under the head “Other income” in the Statement of Profit and Loss.
(b) Income from construction services
Company provides ancillary support services to certain Partner Healthcare Facilities (“PHFs”) which involve
construction of the medical facilities. The Company primarily earns income from PHFs under a revenue sharing agreement over the contract duration.
(c) Dividend
Dividend Income is recognised when the right to receive payment is established.
i. Inventories
Inventories comprise drugs, consumables and implants which are valued at lower of cost and net realizable value. Cost includes the cost of purchase, duties, taxes (other than those recoverable from tax authorities) and other costs incurred in bringing the inventories to their present location and condition. Cost is determined on First In First Out (“FIFO”) basis.
Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and necessary to make the sale.
j. Grants
Grants are recognised when there is reasonable assurance that the grant will be received and all the conditions attached with them will be complied with. When the grant relates to an expense item, it is recognised as income on a systematic basis over the periods that the related costs, for which it is intended to compensate, are expensed. When the grant relates to an asset, it is recognised as
(a) i ncome in equal amounts over the expected useful life of the asset, or
(b) i ncome in proportion to the fulfilment of its obligations, wherever applicable.
k. Taxation
Tax expense comprises deferred tax and current tax expenses. Income tax expense is recognised in Statement of Profit and Loss except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax are also recognised in other comprehensive income or directly in equity, respectively, depending on the recognition of underlying transaction.
Current tax
Current tax assets and liabilities are measured at the amount expected to be recovered from or paid
to the taxation authorities in accordance with the Income Tax Act, 1961 and the Income Computation and Disclosure Standards (“ICDS”) enacted in India by using tax rates and tax laws that are enacted or substantively enacted, at the reporting date.
Management periodically evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.
Deferred tax
Deferred tax is provided using the Balance Sheet approach on temporary differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes at the reporting date.
Deferred tax liabilities are recognised for all taxable temporary differences, except in circumstances where recognition is exempt under Ind AS 12 ‘Income Taxes’. Deferred tax assets are recognised for all deductible temporary differences, the carry forward of unused tax credits and any unused tax losses. Deferred tax assets are recognised to the extent that it is probable that future taxable profit will be available against which the deductible temporary differences, and the carry forward of unused tax credits and unused tax losses can be utilized, except when the deferred tax asset relating to the deductible temporary difference arises from the initial recognition of an asset or liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss.
The carrying amount of deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognised deferred tax assets are re-assessed at each reporting date and are recognised to the extent that it has become probable that future taxable profits will allow the deferred tax asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the reporting date.
Deferred tax assets and deferred tax liabilities are offset if a legally enforceable right exists to set off current tax assets against current tax liabilities and the deferred taxes relate to the same taxable entity and the same taxation authority.
Goods and Services Tax (‘GST’) paid on acquisi¬ tion of assets or on incurring expenses
Expenses and assets are recognised net of the amount of GST paid, except:
(a) When the tax incurred on a purchase of assets or expenses/services is not recoverable from the taxation authority, in which case, the tax paid is recognised as part of the cost of acquisition of the asset or as part of the expense item, as applicable.
(b) When receivables and payables are stated with the amount of tax included, the net amount of tax recoverable from, or payable to, the taxation authority is included as part of other current/non-current assets/liabilities in the Balance Sheet.
l. Non-current assets held for sale and discontinued
operations
The Company classifies non-current assets held for sale if their carrying amounts will be recovered principally through a sale transaction rather than through continuing use. Such assets held for sale are measured at the lower of carrying amount and the fair value less cost to sell. Further, property, plant and equipment and intangible assets are not depreciated or amortized once they are classified as held for sale. Assets and liabilities classified as held for sale are presented separately from other items in the Balance Sheet.
A discontinued operation is a ‘component’ of the Company business that represents a separate line of business that has been disposed off or is held for sale, or is a subsidiary acquired exclusively with a view to resale. Classification as a discontinued operation occurs upon the earlier of disposal or when the operation meets the criteria to be classified as held for sale. The Company considers the guidance in “Ind AS 105 Non-current Assets Held for Sale and Discontinued Operations” to assess whether a divestment asset would qualify the definition of ‘component’ prior to classification into discontinued operation.
m. Borrowing costs
Borrowing costs comprise interest and other costs incurred by the Company in connection with the borrowing of funds, including finance charges in respect of leases. Such costs are recognised in the Statement of Profit and Loss using the Effective Interest Rate (“EIR”) method.
Borrowing costs that are directly attributable to the acquisition or construction of a qualifying asset, being an asset that necessarily takes a substantial period of time to get ready for its intended use or sale, are capitalized as part of the cost of that asset. All other borrowing costs are recognised in the Statement of Profit and Loss within borrowing costs in the period in which they are incurred.
n. Leases
The Company assesses at contract inception whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for an agreed time period in exchange for consideration.
As a lessee
The Company applies a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets. The Company recognises lease liabilities in respect of lease payments to lessors and right- of-use assets representing its right to use the underlying assets.
The Company determines the lease term as the non-cancellable period of the lease together with any periods subject to extension or termination options, where it is reasonably certain that such options will be exercised or not exercised, respectively. In assessing whether the Company is reasonably certain to exercise an option to extend a lease, or not to exercise an option to terminate a lease, it considers all relevant facts and circumstances that create an economic incentive for the Company to exercise the option to do so. The lease term in future periods is reassessed to ensure that the lease term reflects the current economic circumstances.
The Company recognises right-of-use assets at the commencement date of the lease (i.e., the date the underlying asset is available for use). At inception, the right-of-use asset is measured at the initial amount of the lease liability, adjusted for lease
payments made at or before the commencement date and reduced by any lease incentives received. This amount is increased by initial direct costs incurred by the lessee for obtaining the lease and the lessee’s estimate of costs to dismantle, remove or restore the underlying asset or site. The right- of-use asset is subsequently measured at cost less any accumulated depreciation, accumulated impairment losses, if any and adjusted for any remeasurement of the lease liability. The right- of-use asset is depreciated using the straight-line method from the commencement date over the shorter of lease term or useful life of right-of-use asset as mentioned below. Right-of-use assets are tested for impairment whenever there is any indication that their carrying amounts may not be recoverable. Impairment loss, if any, is recognised in the Statement of Profit and Loss.
At the commencement of the lease, the Company recognises lease liabilities measured at the present value of lease payments to be made over the lease term. The lease payments comprise fixed payments (including in substance fixed payments) less any lease incentives receivable, variable lease payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain to be exercised by the Company and payments of penalties for terminating the lease, if the lease term reflects the Company exercising the option to terminate. Variable lease payments that do not depend on an index or a rate are recognised as expenses (unless they are incurred to produce inventories) in the period in which the event or condition that triggers the payment occurs.
In calculating the present value of lease payments, the Company uses its incremental borrowing rate at the lease commencement date because the interest rate implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities is remeasured if there is any modification in terms of the lease (e.g., changes to future payments resulting from a change in an index or rate used to determine such lease payments) or a change in the assessment of an option to purchase the underlying asset.
Short term leases and lease of low value assets
The Company applies the recognition exemptions to its short term leases of property. i.e. those leases that have a lease term of twelve months or less and lease of low value assets. For these leases the Company recognises lease payments as an operating expense on a straight line basis over the term of the lease. This expense is presented within ‘Other expense’ in Statement of Profit and Loss.
As a lessor
Leases in which the Company does not transfer substantially all the risks and rewards of ownership of an asset are classified as operating leases. Where the Company is a lessor under an operating lease, the asset is capitalized under investment property and depreciated over its useful economic life. Payments received under operating leases are recognised in the Statement of Profit and Loss on a straight line basis over the term of the lease.
|